Envestnet Asset Management Inc. Sells 139,575 Shares of The Clorox Company $CLX

Envestnet Asset Management Inc. lowered its stake in The Clorox Company (NYSE:CLX) by 43.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 178,132 shares of the company’s stock after selling 139,575 shares during the quarter. Envestnet Asset Management Inc. owned about 0.15% of Clorox worth $21,964,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Savvy Advisors Inc. boosted its holdings in Clorox by 1.4% during the second quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock worth $768,000 after buying an additional 91 shares during the last quarter. Canandaigua National Bank & Trust Co. raised its position in shares of Clorox by 0.8% in the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock valued at $1,380,000 after acquiring an additional 94 shares during the period. State of Michigan Retirement System boosted its stake in Clorox by 0.3% during the 2nd quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock worth $4,028,000 after acquiring an additional 100 shares during the last quarter. Blue Trust Inc. grew its holdings in Clorox by 8.5% during the third quarter. Blue Trust Inc. now owns 1,333 shares of the company’s stock valued at $164,000 after purchasing an additional 104 shares during the period. Finally, Westhampton Capital LLC increased its stake in Clorox by 0.5% in the third quarter. Westhampton Capital LLC now owns 23,150 shares of the company’s stock valued at $2,854,000 after purchasing an additional 107 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was acquired at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. This represents a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. BNP Paribas Exane raised shares of Clorox from an “underperform” rating to a “neutral” rating in a report on Wednesday. Wells Fargo & Company lifted their target price on Clorox from $108.00 to $115.00 and gave the stock an “equal weight” rating in a report on Friday, January 23rd. JPMorgan Chase & Co. increased their price target on Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a report on Wednesday, February 4th. Deutsche Bank Aktiengesellschaft dropped their price target on Clorox from $114.00 to $112.00 and set a “hold” rating on the stock in a research report on Wednesday, February 4th. Finally, Citigroup increased their target price on Clorox from $109.00 to $115.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 4th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average price target of $118.07.

Clorox Stock Up 1.0%

Shares of CLX stock opened at $125.86 on Friday. The firm’s fifty day moving average price is $107.63 and its two-hundred day moving average price is $113.73. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The Clorox Company has a 1 year low of $96.66 and a 1 year high of $159.04. The firm has a market capitalization of $15.22 billion, a P/E ratio of 20.57, a PEG ratio of 0.61 and a beta of 0.59.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the business earned $1.55 EPS. Clorox’s revenue was down .8% on a year-over-year basis. On average, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th were paid a dividend of $1.24 per share. The ex-dividend date was Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 3.9%. Clorox’s dividend payout ratio is currently 81.05%.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.